- HOME
- Products - New Products/Recommended Products
- New Products November 2010. Tocris Biosciences, Inc.
New Products/Recommended Products
New Products November 2010. Tocris Biosciences, Inc.
We provide the new products from Tocris Biosciences, Inc., which were added in November 2010.
You can move to the Tocris’ website to know the detail of the products when you click the catalogue number or Product name on the list.
| Tocris' cat# | Products | Activity | Size | Price | Add to Cart |
|---|---|---|---|---|---|
|
Aspirin |
Cyclooxygenase (COX)-1 inhibitor; NSAID |
50mg |
12,500 |
|
|
|
YM 202074 |
High affinity, selective metabotropic glutamate receptor type 1 (mGlu1) antagonist |
10mg |
49,500 |
|
|
|
TCS 2314 |
α4β1 (VLA-4) antagonist |
10mg |
57,500 |
|
|
|
Pregabalin |
Anticonvulsant and antiepileptic. Selectively binds the α2δ subunit of voltage-sensitive Ca2+ channels. Sold for research purposes under agreement from Pfizer Inc(1). |
10mg |
44,500 |
|
|
| 4093 |
Hydrocortisone |
Adrenal glucocorticoid; Immunosuppressant and antidiuretic hormone. |
50mg |
12,500 |
|
| 3573 |
SB 612111 hydrochloride |
Selective NOP receptor antagonist. Sold with the permission of GlaxoSmithKline(2). |
10mg |
67,500 |
|
| 4098 |
Carbamazepine |
Inhibitor of neuronal voltage-gated Na+ channels; Exhibits anticonvulsant activity |
50mg |
9,500 |
|
| 4090 |
Doxycycline hyclate |
Broad-spectrum antibiotic and matrix metalloproteinase (MMP) inhibitor; tetracycline derivative |
50mg |
12,500 |
|
| 3730 |
Boc-MLF |
Formyl peptide receptor 1 (FPR1) antagonist |
1mg |
34,500 |
|
| 3951 |
WZ 811 |
Potent chemokine receptor type 4 (CXCR4) antagonist |
10mg |
42,500 |
|
| 3973 |
Latrunculin A |
Inhibitor of actin assembly and polymerization |
100µg |
47,500 |
|
| 4080 |
ATPγS tetralithium salt |
P2 purinergic receptor agonist; ATP (Cat. No. 3245) analog |
10mg |
49,500 |
|
| 4061 |
6-Thioguanine |
Anticancer and immunosuppressive agent |
50mg |
9,500 |
|
| 4091 |
Cyclophosphamide |
Alkylating agent; chemotherapeutic |
50mg |
17,500 |
|
| 3531 |
AT 56 |
Orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) |
10mg |
44,500 |
|
| 4096 |
Clotrimazole |
Cytochrome P450 inhibitor; antifungal |
50mg |
17,500 |
|
| 4089 |
Puromycin dihydrochloride |
Protein synthesis inhibitor |
50mg |
22,500 |
|
| 4095 |
Amiodarone hydrochloride |
Broad spectrum ion channel blocker; antiarrhythmic |
50mg |
14,500 |
|
| 4094 |
Flutamide |
Non-steroidal androgen receptor antagonist |
50mg |
12,500 |
|
| 3113 |
Etifoxine hydrochloride |
Potentiator of GABAA receptors; anxiolytic |
10mg |
42,500 |
|
| 4038 |
TW 37 |
Bcl-2 inhibitor; induces apoptosis |
10mg |
57,500 |
|
| 3727 |
VU 0255035 |
Highly selective muscarinic M1 antagonist |
10mg |
47,500 |
|
| 3518 |
S 24795 |
Partial agonist at α7 nAChR |
10mg |
34,500 |
|
| 3200 |
XAC |
Adenosine receptor antagonist |
10mg |
32,500 |
|
| 3338 |
CART (55-102) (human) |
Neuromodulatory neuropeptide fragment; satiety factor |
100µg |
67,500 |
|
| 3643 |
FR 171113 |
Protease-activated receptor 1 (PAR1) antagonist |
10mg |
52,500 |
|
| 3621 |
UBP 310 |
GLUK5 kainate receptor antagonist |
10mg |
44,500 |
|
| 2913 |
Ro 64-5229 |
Selective, non-competitive mGlu2 antagonist |
10mg |
54,500 |
|
| 4079 |
Niclosamide |
STAT3 inhibitor; also inhibits mTORC1 signaling |
50mg |
24,500 |
|
| 4052 |
Lisuride maleate |
Dopamine (DA) receptor agonist; antiparkinson's agent. |
10mg |
52,500 |
|
| 1644 |
Mesulergine hydrochloride |
5-HT2A and 5-HT2C antagonist. Also D2-like dopamine receptor partial agonist |
10mg |
49,500 |
|
| 4046 |
AC 261066 |
Potent RARβ2 agonist |
10mg |
49,500 |
|
| 3937 |
ANR 94 |
Adenosine A2A (AA2AR) antagonist |
10mg |
49,500 |
|
| 3337 |
CART (55-102) (rat) |
Neuromodulating neuropeptide fragment; satiety factor |
100µg |
77,500 |
|
| 4037 |
BRD 7389 |
p90 ribosomal S6 kinase (RSK) inhibitor |
10mg |
49,500 |
|
| 4058 |
PKC (19-36) |
Pseudosubstrate peptide; inhibitor of PKC |
1mg |
37,500 |
|
| 4034 |
PM 102 |
Antagonist of heparin (Cat. No. 2812) Sold under license(3). |
1mg |
84,500 |
|
| 2830 |
PD 118057 |
Selective Human ether-a-go-go (hERG) K+ channel activator |
10mg |
47,500 |
|
| 3252 |
WWL 70 |
Potent α/β-hydrolase domain 6 (ABHD6) inhibitor |
10mg |
59,500 |
|
| 4045 |
PSI |
Proteasome inhibitor. Also prevents activation of NF-κB |
5mg |
52,500 |
|
(１) Tocris Biosciences, Inc. sells Pregabalin(#3775) for research purposes under agreement from Pfizer Inc.
(２) Tocris Biosciences, Inc. sells SB 612111 hydrochloride(#3573) with the permission of GlaxoSmithKline.
(３) Tocris Biosciences, Inc. sells PM 102(#4034) under license.
Valuable Reminder
Information